129 related articles for article (PubMed ID: 2885889)
1. Long-term effects of L-dopa and procyclidine on neuroleptic-induced extrapyramidal and schizophrenic symptoms.
Chouinard G; Annable L; Mercier P; Turnier L
Psychopharmacol Bull; 1987; 23(1):221-6. PubMed ID: 2885889
[No Abstract] [Full Text] [Related]
2. Tardive dyskinesia and antiparkinsonian medication.
Chouinard G; De Montigny C; Annable L
Am J Psychiatry; 1979 Feb; 136(2):228-9. PubMed ID: 32778
[No Abstract] [Full Text] [Related]
3. [A double-blind study on the effect of dexetimide in the control of neuroleptic-induced extrapyramidal side-effects].
Chen Y
Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1991 Aug; 24(4):197-9, 251. PubMed ID: 1683277
[TBL] [Abstract][Full Text] [Related]
4. Ethopropazine and benztropine in neuroleptic-induced parkinsonism.
Chouinard G; Annable L; Ross-Chouinard A; Kropsky ML
J Clin Psychiatry; 1979 Mar; 40(3):147-52. PubMed ID: 33969
[TBL] [Abstract][Full Text] [Related]
5. Effects of mianserin in neuroleptic-induced parkinsonism.
Korsgaard S; Friis T
Psychopharmacology (Berl); 1986; 88(1):109-11. PubMed ID: 2868480
[TBL] [Abstract][Full Text] [Related]
6. Factors related to tardive dyskinesia.
Chouinard G; Annable L; Ross-Chouinard A; Nestoros JN
Am J Psychiatry; 1979 Jan; 136(1):79-82. PubMed ID: 31802
[TBL] [Abstract][Full Text] [Related]
7. Interactions between procyclidine and neuroleptic drugs. Some pharmacological and clinical aspects.
Bamrah JS; Kumar V; Krska J; Soni SD
Br J Psychiatry; 1986 Dec; 149():726-33. PubMed ID: 2878700
[TBL] [Abstract][Full Text] [Related]
8. Selegiline for neuroleptic-induced parkinsonism.
Gewirtz GR; Sharif Z; Cadet JL; Sarti P; Gorman JM
Pharmacopsychiatry; 1993 Jul; 26(4):128-9. PubMed ID: 7901857
[No Abstract] [Full Text] [Related]
9. Reversal of neuroleptic-induced stupor by procyclidin. Two case reports and their theoretical implications.
Ungvári G; Pethö B
Pharmakopsychiatr Neuropsychopharmakol; 1979 May; 12(3):257-60. PubMed ID: 39302
[TBL] [Abstract][Full Text] [Related]
10. Double-blind comparison of levodopa and procyclidine in parkinsonism, with illustrations of levodopa-induced movement disorders.
Timberlake WH
Neurology; 1970 Dec; 20(12):31-5. PubMed ID: 4924342
[No Abstract] [Full Text] [Related]
11. Adverse effects of anticholinergic medication on positive schizophrenic symptoms.
Johnstone EC; Crow TJ; Ferrier IN; Frith CD; Owens DG; Bourne RC; Gamble SJ
Psychol Med; 1983 Aug; 13(3):513-27. PubMed ID: 6413994
[TBL] [Abstract][Full Text] [Related]
12. No difference in the effect of biperiden and amantadine on parkinsonian- and tardive dyskinesia-type involuntary movements: a double-blind crossover, placebo-controlled study in medicated chronic schizophrenic patients.
Silver H; Geraisy N; Schwartz M
J Clin Psychiatry; 1995 Apr; 56(4):167-70. PubMed ID: 7713856
[TBL] [Abstract][Full Text] [Related]
13. Is prophylactic procyclidine necessary?
Rifkin A; Quitkin F; Kane J; Klein DF
Psychopharmacol Bull; 1977 Jul; 13(3):33-4. PubMed ID: 18756
[No Abstract] [Full Text] [Related]
14. A comparison of piribedil, procyclidine and placebo in the control of phenothiazine-induced parkinsonism.
Mindham RH; Lamb P; Bradley R
Br J Psychiatry; 1977 Jun; 130():581-5. PubMed ID: 326325
[TBL] [Abstract][Full Text] [Related]
15. [Long-latency auditory evoked responses in Parkinson disease and in parkinsonism induced by neuroleptics].
Jacquy J; Mettens P; Blum S; Jacqmotte N; Vanderheyden JE
Acta Neurol Belg; 1993; 93(3):119-29. PubMed ID: 8102219
[TBL] [Abstract][Full Text] [Related]
16. Reduction in neuroleptic-induced movement disorders after a switch to quetiapine in patients with schizophrenia.
Cortese L; Caligiuri MP; Williams R; Schieldrop P; Manchanda R; Malla A; Harricharan R
J Clin Psychopharmacol; 2008 Feb; 28(1):69-73. PubMed ID: 18204344
[TBL] [Abstract][Full Text] [Related]
17. [Neuroleptic large dose therapy of schizophrenias].
Ungvári G; Pethö B
Psychiatr Neurol Med Psychol (Leipz); 1981 Apr; 33(4):230-6. PubMed ID: 6114506
[TBL] [Abstract][Full Text] [Related]
18. Extrapyramidal side effects: a historical perspective.
Rifkin A
J Clin Psychiatry; 1987 Sep; 48 Suppl():3-6. PubMed ID: 2887555
[TBL] [Abstract][Full Text] [Related]
19. Coexistence of severe parkinsonism and tardive dyskinesia as side effects of neuroleptic therapy.
Bitton V; Melamed E
J Clin Psychiatry; 1984 Jan; 45(1):28-30. PubMed ID: 6141157
[TBL] [Abstract][Full Text] [Related]
20. [Experience with the use of midantan for treatment and prevention of the neuroleptic syndrome].
Kamianov IM; Kupisk AG; Katsen IZ
Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(8):1218-23. PubMed ID: 4149581
[No Abstract] [Full Text] [Related]
[Next] [New Search]
